» Authors » Genzhou Liu

Genzhou Liu

Explore the profile of Genzhou Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 151
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ziegelmann M, Hu Y, Xiang Q, Liu G, McLane M, Trost L
Urology . 2023 Mar; 175:126-131. PMID: 36863600
Objective: To evaluate cumulative and incremental changes in penile curvature after each treatment cycle of collagenase clostridium histolyticum (CCH) in men with Peyronie's disease (PD). Methods: Data from 2 phase...
2.
Joseph J, Dayan S, Bhatia A, Fabi S, Shridharani S, Donofrio L, et al.
J Cosmet Dermatol . 2022 Oct; 22(1):177-185. PMID: 36208285
Background: Collagenase clostridium histolyticum-aaes (CCH-aaes) is approved in the United States for moderate-to-severe cellulite in the buttocks of adult women. Aim: Interim analysis to evaluate efficacy/safety of CCH-aaes in the...
3.
Bass L, Kaufman-Janette J, Joseph J, Kaminer M, Clark J, Fabi S, et al.
Plast Reconstr Surg Glob Open . 2022 Jun; 10(5):e4306. PMID: 35646496
Background: Collagen-rich fibrous septae and subcutaneous adipose protrusions play a role in cellulite pathophysiology. Collagenase clostridium histolyticum-aaes (CCH-aaes) injection causes enzymatic release of septae to resolve cellulite depressions and create...
4.
Kaufman-Janette J, Joseph J, Kaminer M, Clark J, Fabi S, Gold M, et al.
Dermatol Surg . 2021 Apr; 47(5):649-656. PMID: 33840781
Background: Fibrous septae play a role in contour alterations associated with cellulite. Objective: To assess collagenase clostridium histolyticum-aaes (CCH) for the treatment of cellulite. Materials And Methods: Two identically designed...
5.
Cohen J, Sadick N, Kirby M, McLane M, Lenderking W, Bender R, et al.
Dermatol Surg . 2020 Oct; 46(12):1628-1635. PMID: 33009069
Background: The Clinician Reported Photonumeric Cellulite Severity Scale (CR-PCSS) and Patient Reported PCSS (PR-PCSS) are newly developed tools for assessing cellulite severity. Objective: To report on the reliability, validity, and...
6.
Goldstein I, Lipshultz L, McLane M, Hu Y, Xiang Q, Liu G, et al.
J Urol . 2020 Jan; 203(6):1191-1197. PMID: 31922462
Purpose: We assessed the long-term safety and immunogenicity profile of collagenase clostridium histolyticum and characterized penile curvature deformity over time in patients previously treated for Peyronie's disease. Materials And Methods:...
7.
Sadick N, Goldman M, Liu G, Shusterman N, McLane M, Hurley D, et al.
Dermatol Surg . 2019 Mar; 45(8):1047-1056. PMID: 30829779
Background: Edematous fibrosclerotic panniculopathy (EFP; cellulite) is associated with thickening and contraction of collagen-rich subdermal septae. Collagenase clostridium histolyticum (CCH) may disrupt collagen-rich septae. Objective: To evaluate the safety and...
8.
Ralph D, Raheem A, Liu G
J Sex Med . 2017 Oct; 14(11):1430-1437. PMID: 28974406
Background: Collagenase Clostridium histolyticum (CCH) is indicated for the treatment of penile curvature in adult men with Peyronie's disease (PD) with palpable plaque and curvature deformity of at least 30°...
9.
Serefoglu E, Smith T, Kaufman G, Liu G, Yafi F, Hellstrom W
Urology . 2017 May; 107:155-160. PMID: 28554517
Objective: To elucidate patient characteristics that impact symptom-related bother and erectile function in patients with Peyronie disease (PD). Methods: A post hoc analysis used data from patients with PD (ie,...
10.
Hellstrom W, Tan R, Liu G
Urology . 2017 May; 106:237.e9-237.e14. PMID: 28502596
Objective: To examine the safety of collagenase clostridium histolyticum (CCH) in adult men with penile curvature deformity <30°. CCH is indicated for treatment of Peyronie disease in adult men with...